Nasdaq

Medtronic Announces FDA Approval Of Simplera CGM; Partners With Abbott To Expand CGM Options

(RTTNews) - Medtronic plc (MDT) announced the U.S. Food and Drug Administration approval for Simplera continuous glucose monitor, or CGM, the company's first disposable, all-in-one CGM that's half the ...
Healio

Switch from intermittently scanned to real-time CGM a ‘therapeutic option’

Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes had improvements in glycemic control after switching from an intermittently scanned ...
Business Wire

DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, will showcase for the first time its new global ...
Business Wire

Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life’ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

PARSIPPANY, N.J. & GERMANTOWN, Md.--(BUSINESS WIRE)--Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused ...
Healio

Professional device can encourage adoption of CGM as standard of care for diabetes

Please provide your email address to receive an email when new articles are posted on . Technology advancements during the past 5 to 10 years have provided clinicians and patients with better ways to ...
The American Journal of Managed Care

Exploratory Study of Selected Stakeholder Insights Into Continuous Glucose Monitoring in T2D With Risk-Sharing Agreements

Continuous glucose monitoring (CGM) is underutilized in non-insulin-treated type 2 diabetes (T2D) despite evidence of ...
Nasdaq

Ascensia Diabetes Care and Senseonics Announce 'The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

Almost 1 in 2 people with diabetes using a short-term CGM are not fully satisfied with their current systemi For the 37 million people living with diabetes in the U.S.ii, CGM has become an ...
Business Insider

Ascensia Diabetes Care and Senseonics Announce 'The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

Almost 1 in 2 people with diabetes using a short-term CGM are not fully satisfied with their current system i PARSIPPANY, N.J., Oct. 9, 2023 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes ...